AMRI Realigns Discovery Services to Support Customer Demand
Tighter Integration of Biology Strengthens Integrated Drug Discovery Platform Albany, NY (November 30, 2012) – AMRI (NASDAQ: AMRI) announced today that as a next step in its...
Oxygen Biotherapeutics Engages PPD to Execute Remainder of Phase IIb Clinical Trial to Evaluate the Safety and Tolerability of Oxycyte® in Severe Traumatic Brain Injury
MORRISVILLE, N.C.--Oxygen Biotherapeutics, Inc. ("OBI") (NASDAQ: OXBT), announced today that it is partnering with Pharmaceutical Product Development, LLC (PPD), a global contract research...
Medpace, Inc. Acquires MediTech Strategic Consultants B.V., a European-Based Contract Research Organization (CRO) Specializing in Medical Device
CINCINNATI, OH, Nov 20, 2012 -- Medpace, a privately held, global, full-service contract research organization (CRO) announced that it has acquired MediTech Strategic Consultants B.V. (MediTech), a...
Onyx Scientific Limited Bolsters U.S. Team
Onyx Scientific Limited Bolsters U.S. Team 11/19/2012 12:18:41 PM November 2012 -- CHEMISTRY CRO Onyx Scientific has strengthened its US presence with the appointment of a Chicago-based business...
QPS EXPANDS PHASE I CLINIC IN GRONINGEN, THE NETHERLANDS, TO ACCOMMODATE CLIENT DEMAND
New hospital based clinic built for efficient conduct of larger and more complex Phase I studies Groningen, The Netherlands – QPS Holdings, LLC today announced the completion of a 24-bed annex...
ShangPharma Announces Third Quarter 2012 Results
SHANGHAI, Nov. 20, 2012 -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development...
Chiromics and Bristol-Myers Squibb Form Drug Discovery Strategic Alliance
PRINCETON, N.J.--Chiromics LLC today announced a strategic research alliance with Bristol-Myers Squibb Company (NYSE:BMY) which includes grants of non-exclusive license for use of Chiromics' chemical...
Chiromics and GlaxoSmithKline Enter into Collaboration
PRINCETON, N.J.--Chiromics LLC today announced a collaboration with GlaxoSmithKline (GSK) to discover novel classes of small molecules against certain biological targets. Chiromics' compound...
Aptuit and GSK Extend Strategic Partnership
Greenwich, CT, November 13, 2012 – Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated...
WuXi PharmaTech Announces Third-Quarter 2012 Results
SHANGHAI, Nov. 12, 2012 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries,...
Agility Clinical Expands Consulting Services to More Broadly Serve Small and Virtual Biopharma and Device Companies
CARLSBAD, Calif., Nov. 8, 2012 -- Agility Clinical, Inc., a specialty consulting and clinical research organization, has expanded its stand-alone consulting services to more broadly serve the unmet...
Quintiles Study Confirms Validity of Data from Patients Recruited Over the Internet
RESEARCH TRIANGLE PARK, NC – November 5, 2012 – A new pilot study from Quintiles' Digital Patient Unit (DPU) confirms the reliability of patient-reported outcomes collected via patients...
ICON Launches New Functional Service Provision (FSP) Strategy
FSP and resourcing services consolidated into a single division, DOCS Dublin, Ireland, 6 November, 2012 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced...
DiscoveRx corporation acquires BioSeek
Fremont, California, November 7th, 2012 - DiscoveRx today announced the acquisition of BioSeek, a drug discovery services company based in South San Francisco, California. BioSeek's phenotypic...
Clinical Research Advantage and Radiant Research Form the Largest and Most Therapeutically Diverse Site Management Organization in the United States
TEMPE, Ariz.--CRA Holdings, LLC announced today that it has acquired Radiant Research, Inc. CRA Holdings is the company that also owns Clinical Research Advantage (CRA), another major player in the...
AMRI Announces Third Quarter 2012 Results
Albany, NY (November 6, 2012) — AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter and year-to-date period ended September 30, 2012. Highlights for the...
Cytovance® Biologics, Inc. Awarded Biopharmaceutical Development and Manufacturing Contract by Fountain BioPharma, Inc.
Oklahoma City, OK -- Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel...
Pacific BioLabs Acquires Bay Bioanalytical Laboratory
HERCULES, CA – November 1, 2012 – Pacific BioLabs (PBL), The Service Leader in Bioscience Testing, has acquired Bay Bioanalytical Laboratory (BBL), adding analytical and bioanalytical...
ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million.
Highlights – Third Quarter Fiscal 2012 ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its...
Charles River Laboratories Announces Third-Quarter 2012 Results from Continuing Operations
WILMINGTON, Mass.--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2012. For the quarter, net sales from continuing operations were...
